中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2013年
1期
22-26
,共5页
顾晔%姜格宁%周晓%姜洪斌%任胜祥%李爱武%张海平%汪浩
顧曄%薑格寧%週曉%薑洪斌%任勝祥%李愛武%張海平%汪浩
고엽%강격저%주효%강홍빈%임성상%리애무%장해평%왕호
淋巴结%活组织检查,针吸%腔内超声检查
淋巴結%活組織檢查,針吸%腔內超聲檢查
림파결%활조직검사,침흡%강내초성검사
Lymph nodes%Biopsy,needle%Ultrasonography,interventional
目的 探讨气管内超声引导下针吸活检术(EBUS-TBNA)对肺门纵隔肿物的诊断价值.方法 对837例胸部CT或正电子发射体层摄影术(PET)-CT提示肺门纵隔淋巴结肿大和(或)位于气管或支气管周围肿块的患者进行EBUS-TBNA检查.获取病理组织标本,同期进行有创检查或随访,得到最终结果,验证EBUS-TBNA的准确性.结果 共穿刺淋巴结1631例次,平均1.95次/例,穿刺成功率100%,其中4R组与7组淋巴结分别占穿刺总数的43%和34%,肺癌诊断率为94.11%;其中鳞癌89例,占19.22%;腺癌150例,占32.40%;小细胞癌109例,占23.54%;非小细胞癌-组织学类型不明确型44例,占9.50%;腺鳞癌35例,占7.56%;其他类型36例,占7.78%.结核病诊断率为85.50%;结节病诊断率为55.88%;经统计分析,得出EBUS-TBNA总体敏感度为94.02%,特异度为100%,阳性预测值100%,阴性预测值61.91%,准确率94.56%.除穿刺部位少许出血外,无其他并发症,未见气胸、纵隔气肿、大血管损伤等严重并发症.结论 EBUS-TBNA作为一种微创,便利,低风险的操作,对于纵隔和肺门淋巴结以及肿块的穿刺诊断有着较高的实用价值.
目的 探討氣管內超聲引導下針吸活檢術(EBUS-TBNA)對肺門縱隔腫物的診斷價值.方法 對837例胸部CT或正電子髮射體層攝影術(PET)-CT提示肺門縱隔淋巴結腫大和(或)位于氣管或支氣管週圍腫塊的患者進行EBUS-TBNA檢查.穫取病理組織標本,同期進行有創檢查或隨訪,得到最終結果,驗證EBUS-TBNA的準確性.結果 共穿刺淋巴結1631例次,平均1.95次/例,穿刺成功率100%,其中4R組與7組淋巴結分彆佔穿刺總數的43%和34%,肺癌診斷率為94.11%;其中鱗癌89例,佔19.22%;腺癌150例,佔32.40%;小細胞癌109例,佔23.54%;非小細胞癌-組織學類型不明確型44例,佔9.50%;腺鱗癌35例,佔7.56%;其他類型36例,佔7.78%.結覈病診斷率為85.50%;結節病診斷率為55.88%;經統計分析,得齣EBUS-TBNA總體敏感度為94.02%,特異度為100%,暘性預測值100%,陰性預測值61.91%,準確率94.56%.除穿刺部位少許齣血外,無其他併髮癥,未見氣胸、縱隔氣腫、大血管損傷等嚴重併髮癥.結論 EBUS-TBNA作為一種微創,便利,低風險的操作,對于縱隔和肺門淋巴結以及腫塊的穿刺診斷有著較高的實用價值.
목적 탐토기관내초성인도하침흡활검술(EBUS-TBNA)대폐문종격종물적진단개치.방법 대837례흉부CT혹정전자발사체층섭영술(PET)-CT제시폐문종격림파결종대화(혹)위우기관혹지기관주위종괴적환자진행EBUS-TBNA검사.획취병리조직표본,동기진행유창검사혹수방,득도최종결과,험증EBUS-TBNA적준학성.결과 공천자림파결1631례차,평균1.95차/례,천자성공솔100%,기중4R조여7조림파결분별점천자총수적43%화34%,폐암진단솔위94.11%;기중린암89례,점19.22%;선암150례,점32.40%;소세포암109례,점23.54%;비소세포암-조직학류형불명학형44례,점9.50%;선린암35례,점7.56%;기타류형36례,점7.78%.결핵병진단솔위85.50%;결절병진단솔위55.88%;경통계분석,득출EBUS-TBNA총체민감도위94.02%,특이도위100%,양성예측치100%,음성예측치61.91%,준학솔94.56%.제천자부위소허출혈외,무기타병발증,미견기흉、종격기종、대혈관손상등엄중병발증.결론 EBUS-TBNA작위일충미창,편리,저풍험적조작,대우종격화폐문림파결이급종괴적천자진단유착교고적실용개치.
Objective To explore the diagnostic values of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in patients with hilar and mediastinal tumors.Methods A total of 837 patients with chest CT or PET/CT confirmed mediastinal/hilar lymphadenopathy and or tumors in (or around) the trachea or bronchi,were evaluated by EBUS-TBNA examination.Pathological study or follow-up visit was carried out in the same period to make a final diagnosis,and therefore to verify the accuracy of EBUS-TBNA.Result The study punctured 1631 lymph nodes totally,with an average of 1.95 times per case.The 4R group and the 7th group of lymph nodes accounted for 43% and 34%,respectively.The success rate of TBNA was 100%.The diagnosis rates of lung cancer was 94.11%,of which squamous cell carcinoma accounted for 19.22% (89 cases),adenocarcinoma 32.40% (150 cases),small cell carcinoma 23.54% (109 cases),non-small cell carcinoma of unknown histological type 9.50% (44 cases),adenosquamous carcinoma 7.56% (35 cases),and other types 7.78% (36 cases).The diagnosis rate of tuberculosis was 85.50%,and that of sarcoidosis was 55.88%.The overall sensitivity of EBUS-TBNA was 94.02%,specificity 100%,positive predictive value 100%,negative predictive value 61.91%,and the accuracy was 94.56%.Besides mild bleeding in the puncture site,no other complications occurred,and there were no severe complications such as pneumothorax,pneumomediastinum,or major vascular injury.Conclusion EBUS-TBNA is of high value as a minimnally invasive,convenient,and low-risk procedure for the diagnosis of mediastinal and hilar lymphadenopathy and tumors.